Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Malik

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
European Journal of Heart Failure|April 5, 2020
Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal diseaseMariam E Malik, Christian Madelaire, Maria D'Souza, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 22, 2024
Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patientsMarte Austreim, Nina Nouhravesh, Mariam E Malik, et al.
American Heart Journal|August 31, 2024
Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997 to 2017Sørine Lundberg, Pauline Knigge, Jarl E Strange, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Journal of the American Heart Association|March 12, 2024
Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016Pauline Knigge, Sørine Lundberg, Jarl E Strange, et al.
Molecular Psychiatry|December 3, 2014
A2A adenosine receptor deletion is protective in a mouse model of TauopathyC Laurent, S Burnouf, B Ferry, et al.
Molecular Psychiatry|July 29, 2015
A2A adenosine receptor deletion is protective in a mouse model of TauopathyC Laurent, S Burnouf, B Ferry, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
European Journal of Heart Failure|April 5, 2020
Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal diseaseMariam E Malik, Christian Madelaire, Maria D'Souza, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 22, 2024
Temporal trends in mortality, heart failure hospitalization, and stroke in heart failure patients with and without atrial fibrillation: a nationwide study from 1997 to 2018 on 152 059 patientsMarte Austreim, Nina Nouhravesh, Mariam E Malik, et al.
American Heart Journal|August 31, 2024
Temporal trends in infection-related hospitalizations among patients with heart failure: A Danish nationwide study from 1997 to 2017Sørine Lundberg, Pauline Knigge, Jarl E Strange, et al.
Therapeutic Innovation & Regulatory Science|February 20, 2020
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018Jan Willem van der Laan, Charles T Benson, Walter Janssens, et al.
Journal of the American Heart Association|March 12, 2024
Temporal Trends in the Initiation of Dialysis Among Patients With Heart Failure With or Without Diabetes: A Nationwide Study From 2002 to 2016Pauline Knigge, Sørine Lundberg, Jarl E Strange, et al.
Molecular Psychiatry|December 3, 2014
A2A adenosine receptor deletion is protective in a mouse model of TauopathyC Laurent, S Burnouf, B Ferry, et al.
Molecular Psychiatry|July 29, 2015
A2A adenosine receptor deletion is protective in a mouse model of TauopathyC Laurent, S Burnouf, B Ferry, et al.
Pageof 7